Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday ↗

September 27, 2022

Gainers

Via Benzinga

Why LAVA Therapeutics Stock Is Up More Than 100% Today ↗

September 26, 2022

LAVA Therapeutics N.V.

Via Benzinga

LAVA Therapeutics Skyrockets After Cancer Agreement With Seagen ↗

September 26, 2022

Via Benzinga

Analyst Ratings for Seagen ↗

September 13, 2022

Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings:

Via Benzinga

Where Seagen Stands With Analysts ↗

September 13, 2022

Analysts have provided the following ratings for Seagen (NASDAQ:SGEN) within the last quarter:

Via Benzinga

Nasdaq Turns Lower; Crude Oil Drops Sharply ↗

September 26, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite turning negative on Monday.

Via Benzinga

Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

September 26, 2022

Gainers

Via Benzinga

LAVA Therapeutics (NASDAQ: LVTX) Enters into Global Licensing Agreement with Seagen (NASDAQ: SGEN) to Develop and Commercialize LAVA-1223

September 26, 2022

LAVA Therapeutics N.V. (NASDAQ: LVTX) is engaged as a clinical-stage oncology company, which is focused on the research and development

Via Spotlight Growth

Dow Drops Over 100 Points; Crude Oil Rises Over 1% ↗

September 26, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones dropping more than 100 points on Monday.

Via Benzinga

What Is Going on With Lava Therapeutics (LVTX) Stock Today? ↗

September 26, 2022

Lava Therapeutics (LVTX) stock is rocketing higher on Monday as investors react to an exclusive global license agreement with Seagen (SGEN).

Via InvestorPlace

US Stocks Mostly Higher; Nasdaq Rises Over 100 Points ↗

September 26, 2022

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.

Via Benzinga

Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engager for EGFR-Expressing Solid Tumors

September 26, 2022

From Seagen Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Seagen Announces TUKYSA® (tucatinib) in Combination with Trastuzumab Granted Priority Review by FDA for Previously Treated HER2-Positive Metastatic Colorectal Cancer

September 19, 2022

From Seagen Inc.

Via Business Wire

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

September 13, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

This Analyst Slashes PT On Rent the Runway By Around 43%, Plus JP Morgan Predicts $84 For Oracle ↗

September 13, 2022

Credit Suisse cut the price target for Rent the Runway, Inc. (NASDAQ: RENT) from $7 to $4. Rent the Runway shares fell 30.6% to trade at $3.42 on Tuesday.

Via Benzinga

Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer

September 12, 2022

From Seagen Inc.

Via Business Wire

Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today ↗

September 11, 2022

In two new studies, Keytruda doubled patients' survival rate after five years.

Via Investor's Business Daily

Seagen to Highlight Research in Urothelial and Colorectal Cancers at 2022 European Society for Medical Oncology (ESMO) Congress

September 07, 2022

From Seagen Inc.

Via Business Wire

Seagen to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

September 07, 2022

From Seagen Inc.

Via Business Wire

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

These names are benefitting from M&A, clinical data and promising regulatory actions.

Via Investor's Business Daily

Apple, Amazon, HP And Other Big Losers From Friday ↗

August 29, 2022

U.S. stocks closed sharply lower with the Dow Jones tumbling more than 1,000 points on Friday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday ↗

August 29, 2022

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

Why Farfetch Is Trading Higher By 32%, Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

August 26, 2022

Gainers Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

Merck's Rumored $40 Billion Seagen Takeover Hits A Snag On Price ↗

August 26, 2022

The companies could still reach a deal, but have failed to see eye to eye on price.

Via Investor's Business Daily

Benzinga Before The Bell: Elon Musk's Demand For Broad Twitter Data Dismissed, Xiaomi Wants To Join EV Race, Bed Bath & Beyond Plans To Share Turnaround Strategy Next Week And Other Top Financial Stories Friday, August 26 ↗

August 26, 2022

CNBC The Aviation Sector Is Slammed By Sky-High Rents

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 26, 2022

Via Benzinga

Dell Technologies, Open Text And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

August 26, 2022

Affirm Holdings, Inc. (NASDAQ: AFRM) shares fell 12.7% to $27.27 in pre-market trading after the company reported worse-than-expected Q4 EPS results and issued Q1 FY23 sales guidance below estimates.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 26, 2022

We're starting off the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.